These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 1723451

  • 1. Treatment of mild hypertension.
    Fodor JG, Chockalingam A.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S25-8; discussion S28-9. PubMed ID: 1723451
    [Abstract] [Full Text] [Related]

  • 2. Low-dose nitrendipine in mild hypertension: a double-blind, placebo-controlled, comparative study.
    Lederle RM, Klaus D, Wilk S, Knaup G.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S48-50. PubMed ID: 1723455
    [Abstract] [Full Text] [Related]

  • 3. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [Abstract] [Full Text] [Related]

  • 4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Clerson P.
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jan; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo.
    Fodor JG, Chockalingam A, Cifkova R, Strong HA, Cobby J, Mukherjee J.
    Can J Cardiol; 1991 Jun; 7(5):223-8. PubMed ID: 1860094
    [Abstract] [Full Text] [Related]

  • 9. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 10. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA, Glasser SP, Ram CV, McMahon SG, Vanov SK, Leibowitz DA.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 13. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension.
    Abelardo NS, Ramos EF, Mendoza VL, Sulit YQ, Mitchell MJ.
    J Hum Hypertens; 1989 Feb; 3(1):57-9. PubMed ID: 2657058
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, randomized, comparative study of nitrendipine and enalapril in elderly hypertensive patients.
    Poncelet P, Werquin S, Warembourg A, Ansquer JC, Boussac I, Lekieffre J, Carre A.
    J Cardiovasc Pharmacol; 1991 Feb; 18 Suppl 1():S67-70. PubMed ID: 1723461
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG, Pearce GL, Danoff TM.
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM.
    J Cardiovasc Pharmacol; 1988 Jul; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 19. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 20. Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.
    Dolben J, Vora J, Smith H, Luzio S, Griffiths D, Vølund A, Owens DR.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 1():S94-7. PubMed ID: 1723468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.